Raymage is Decision/Risk Analysis in China that focus on cloud platform research business. Founded in 2014. They cover business area such as developer, medical imaging technology, digital imaging equipment production, medical imaging cloud platform research, development, cloud service, primary medical institution.
2014
( 10 years old in 2024 )
Cloud Platform Research
-
6th Floor, Scientific Research Building, No. 9 Duxue Road, Xili University Town
Xili Street, Nanshan District
Shenzhen, Guangdong
China
Private
developermedical imaging technologydigital imaging equipment productionmedical imaging cloud platform researchdevelopmentcloud serviceprimary medical institution
* We use standard office opening hours in near Raymage's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Raymage is Decision/Risk Analysis business from China that founded in 2014 (10 years old in 2024), Raymage business is focusing on Cloud Platform Research.
Raymage headquarter office and corporate office address is located in 6th Floor, Scientific Research Building, No. 9 Duxue Road, Xili University Town Xili Street, Nanshan District Shenzhen, Guangdong China.
Raymage was founded in China.
In 2024, Raymage is currently focus on cloud platform research sector.
Above is snippet of Google Trends for "cloud platform research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Raymage, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.